throbber
Eur. J. Biochem. 269, 1589–1599 (2002) (cid:211) FEBS 2002
`
`R E V I E W A R T I C L E
`
`The human b-globin locus control region
`A center of attraction
`
`Padraic P. Levings and Jo¨ rg Bungert
`
`Department of Biochemistry and Molecular Biology, Gene Therapy Center, Center for Mammalian Genetics, College of Medicine,
`University of Florida, Gainesville, FL, USA
`
`The human b-globin gene locus is the subject of intense
`study, and over the past two decades a wealth of information
`has accumulated on how tissue-specific and stage-specific
`expression of its genes is achieved. The data are extensive and
`it would be di(cid:129)cult, if not impossible, to formulate a com-
`prehensive model integrating every aspect of what is cur-
`rently known. In this review, we introduce the fundamental
`characteristics of globin locus regulation as well as questions
`on which much of the current research is predicated. We then
`outline a hypothesis that encompasses more recent results,
`focusing on the modification of higher-order chromatin
`structure and recruitment of transcription complexes to the
`globin locus. The essence of this hypothesis is that the locus
`control region (LCR) is a genetic entity highly accessible to
`
`and capable of recruiting, with great e(cid:129)ciency, chromatin-
`modifying, coactivator, and transcription complexes. These
`complexes are used to establish accessible chromatin
`domains, allowing basal factors to be loaded on to specific
`globin gene promoters in a developmental stage-specific
`manner. We conceptually divide this process into four steps:
`(a) generation of a highly accessible LCR holocomplex;
`(b) recruitment of transcription and chromatin-modifying
`complexes to the LCR; (c) establishment of chromatin
`domains permissive for transcription; (d) transfer of tran-
`scription complexes to globin gene promoters.
`
`Keywords: chromatin domains; globin genes;
`transcription; locus control region; transcription.
`
`intergenic
`
`O R G A N I Z A T I O N A N D S T R U C T U R E
`O F T H E H U M A N b-G L O B I N L O C U S
`The five genes of the human b-globin locus are arranged in a
`linear array on chromosome 11 and are expressed in a
`developmental stage-specific manner in erythroid cells
`(Fig. 1) [1]. The e-globin gene is transcribed in the embry-
`onic yolk sac and located at the 5¢ end. After the switch in
`the site of hematopoiesis from the yolk sac to the fetal liver,
`the e-gene is repressed and the two c-globin genes, located
`downstream of e, are activated. In a second switch,
`completed shortly after birth, the bone marrow becomes
`the major site of hematopoiesis, coincident with activation
`of the adult b-globin gene, while the c-globin genes become
`silenced. The d-globin gene is also activated in erythroid cells
`derived from bone marrow hematopoiesis but is only
`expressed at levels less than 5% of that of the b-globin gene.
`The complex program of
`transcriptional regulation
`leading to the differentiation and developmental stage-
`specific expression in the globin locus is mediated by DNA-
`regulatory sequences located both proximal and distal to the
`
`Correspondence to J. Bungert, Department of Biochemistry and
`Molecular Biology, Gene Therapy Center, Center for Mammalian
`Genetics, College of Medicine, University of Florida, 1600 SW Archer
`Road, Gainesville, FL 32610, USA. Fax: + 352 392 2953,
`Tel.: + 352 392 0121, E-mail: jbungert@college.med.ufl.edu
`Abbreviations: LCR, locus control region; HS, hypersensitive; EKLF,
`erythroid kru¨ ppel-like factor; MEL cells, murine erythroleukemia
`cells; ICD, interchromosomal domain; HLH, helix–loop–helix.
`(Received 15 November 2001, revised 16 January 2002, accepted
`21 January 2002)
`
`gene-coding regions. The most prominent distal regulatory
`element in the human b-globin locus is the locus control
`region (LCR), located from about 6 to 22 kb upstream of
`the e-globin gene [2–4]. The LCR is composed of several
`domains that exhibit extremely high sensitivity to DNase I
`in erythroid cells (called hypersensitive, or HS, sites), and is
`required for high-level globin gene expression at all develop-
`mental stages [5].
`The entire b-globin locus remains in an inactive DNase
`I-resistant chromatin conformation in cells in which the
`globin genes are not expressed. In erythroid cells, the entire
`locus shows a higher degree of sensitivity to DNase I,
`indicating that it is in a more open and accessible chromatin
`configuration [6]. Studies analyzing the human b-globin
`locus in transgenic mice have shown that sensitivity to
`DNase I in specific regions of the globin locus varies and
`depends on the developmental stage of erythropoiesis (yolk
`sac, fetal liver, adult spleen) [7]. The LCR remains sensitive
`to DNase I at all developmental stages, whereas sensitivity
`to DNase I in the region containing the e-globin and
`c-globin genes is higher in embryonic cells, and DNase I
`sensitivity in the region containing the d-globin and b-globin
`gene is higher in adult erythroid cells [7].
`This review focuses on the regulation of the human
`b-globin gene locus, and we would like to refer the reader to
`another recent review that compares the regulation of
`different complex gene loci [8].
`
`D E V E L O P M E N T A L S T A G E - S P E C I F I C
`E X P R E S S I O N O F T H E G L O B I N G E N E S
`
`The stage-specific activation and repression of the individual
`globin genes during development is regulated by various
`
`GENENTECH 2013
`GENZYME V. GENENTECH
`IPR2016-00383
`
`

`
`1590 P. P. Levings and J. Bungert (Eur. J. Biochem. 269)
`
`(cid:211) FEBS 2002
`
`e-promoter EKLF binding site leads to expression of the
`e-globin gene at the adult stage [15]. This observation
`indicates that repression of the e-globin gene at the definitive
`stage is in part due to proteins that interfere with the
`interaction of the transcriptional activator EKLF.
`There is also increasing evidence for the presence of stage-
`specific factors regulating the expression of the two c-globin
`genes. In particular, it has been shown that CACCC and
`CCAAT motifs are required for activation of the c-globin
`genes. The CACCC element is bound by members of the
`family of kru¨ ppel-like zinc finger (KLF) proteins [16].
`Potential candidates for proteins acting through this
`element are EKLF, FKLF, FKLF-2, and BKLF [17]. The
`CCAAT box interacts with the heterotrimeric protein NF-Y
`[18], which appears to play a role similar to EKLF and may
`recruit chromatin-remodeling activities to the c-globin gene
`promoters at the fetal stage.
`The combined data demonstrate that stage-specific
`factors interacting with individual globin gene promoters
`play important roles in the regulation of local chromatin
`structure and stage-specific gene expression.
`Another important parameter regulating the stage-speci-
`fic activity of the globin genes is the relative position of the
`genes with respect to the LCR [19,20]. Inverting the genes
`relative to the LCR leads to an inappropriate expression of
`the adult b-globin gene at the embryonic stage and the
`absence of e-globin gene expression at all stages [21].
`Although the mechanistic basis for the importance of gene
`order in the globin locus is not entirely clear, it is in
`agreement with the hypothesis that the genes in the globin
`locus are competitively regulated by the LCR [22,23] and
`suggests that repressors restrict the ability of the LCR to
`activate transcription of only one or two genes at specific
`developmental stages. These factors could either modulate
`the chromatin structure around the inactive genes [7] or
`interact with globin gene promoters to prevent the interac-
`tion of a gene with the LCR in a developmental stage-
`specific manner [15].
`
`S T R U C T U R E A N D F U N C T I O N
`O F T H E L C R
`
`The overall organization of the LCR is conserved among
`several vertebrate species. The conservation of individual
`factor-binding sites within the HS core elements implies that
`these sites are important for LCR function [24]. However,
`this by no means leads to the conclusion that transcription
`factor-binding sites that are not conserved are functionally
`irrelevant. Some of these nonconserved sites may mediate
`novel functions acquired during evolution. For example, the
`developmental pattern of globin gene expression in humans
`is quite different from that in mice (Fig. 1) [25].
`Whereas almost all studies agree that the human b-globin
`LCR is required for high-level transcription of all b-like
`globin genes, the question of whether the LCR also
`regulates the chromatin structure over the whole locus is a
`matter of debate. Deletion of the complete LCR from either
`the murine or human locus does not appear to change the
`overall general sensitivity to DNase I of the locus, indicating
`that the LCR is not required for unfolding of higher-order
`chromatin structure [26–28]. Our understanding of the
`structural basis for general DNase I sensitivity of chromatin
`is limited. Loci permissive for transcription are within
`
`Fig. 1. Diagrammatic representation of the human b-globin gene locus
`(not drawn to scale). The five genes of the human b-globin gene locus
`are arranged in linear order reflecting their expression during develop-
`ment. The LCR is represented as the sum of the five HS sites. It should
`be noted that additional HS sites were mapped 5¢ to HS5 [95], but it
`is currently not known whether these sites participate in globin gene
`regulation or whether they are associated with the regulation of
`genes located upstream of the globin locus. The HS core elements are
`200–400 bp in size and separated from each other by more than 2 kb.
`During normal human development, the e-globin gene is expressed in
`the first trimester in erythroid cells derived from yolk sac hematopoi-
`esis. The c-globin genes are expressed in erythroid cells generated in the
`fetal liver until around birth. The adult b-globin gene is expressed
`around birth predominantly in cells derived from bone marrow
`hematopoiesis. The expression pattern of the human globin genes is
`somewhat different when analyzed in the context of transgenic mice
`[96], where the e-globin and c-globin genes are coexpressed in the
`embryonic yolk sac and the b-globin gene is expressed at high levels in
`fetal liver and circulating erythroid cells from bone marrow.
`
`mechanisms. First, genetic information governing the stage-
`specificity for all b-like globin genes is located in gene
`proximal regions. These elements represent transcription
`factor-binding sites that recruit proteins or protein com-
`plexes in a stage-specific manner. Examples exist for the
`presence of both positive and negative acting factors that
`turn genes on or off at a specific developmental stage [1].
`The most extensively studied stage-specific activator is
`EKLF (erythroid kru¨ ppel like factor), which is crucial for
`human b-globin gene expression [9]. Gene-ablation studies
`in mice have shown that EKLF deficiency leads to a specific
`reduction in adult b-globin gene expression, with a
`concomitant increase in expression of the fetal genes [10–
`12]. Associated with the dramatic decrease in adult b-globin
`gene expression is a reduction in DNase I HS site formation
`in the b-globin gene promoter as well as in LCR element
`HS3 [13]. These results demonstrate that EKLF is critically
`required for the expression of the adult b-globin gene and
`suggest that EKLF may exert part of its function by
`changing chromatin structure. Indeed, Armstrong et al. [14]
`showed that EKLF recruits chromatin-remodeling factors
`to the adult b-globin promoter and that this remodeling
`activity was sufficient to activate b-globin gene expression in
`an erythroid-specific manner in vitro. EKLF acts in a
`sequence-specific context to activate transcription of the
`b-globin gene [15]. Although both the e-globin and b-globin
`gene promoters harbor binding sites for EKLF, only the
`b-globin gene is expressed at definitive stages of erythro-
`poiesis. Disruption of direct repeat elements flanking the
`
`

`
`(cid:211) FEBS 2002
`
`Multistep model for locus control region function (Eur. J. Biochem. 269) 1591
`
`domains of general DNase I sensitivity. However, the
`presence of a DNase I-sensitive domain does not indicate
`that all of the genes residing within the domain are
`transcribed or even that they are permissive for transcription
`[28]. In this respect the LCR could be involved in regulating
`chromatin structure beyond the formation of a general
`DNase I-sensitive domain, for example by regulating the
`modification of histone tails (methylation, acetylation,
`phosphorylation) [29].
`It is unquestionable that the LCR provides an open and
`accessible chromatin structure at ectopic sites in transgenic
`assays [5]. Whether this is true for all chromosomal
`positions is not known, because there are no data available
`that demonstrate LCRs function from within a defined
`heterochromatic
`environment. However, globin gene
`expression constructs reveal strong position-of-integration
`effects in transgenic assays in the absence of the LCR,
`suggesting that at most sites the LCR is able to confer an
`accessible chromatin structure. It is important to understand
`that any model describing globin gene regulation must
`address the LCR’s ability to open chromatin and enhance
`globin gene expression at ectopic sites.
`Current models propose that the individual HS core
`elements interact to form a higher-order structure, com-
`monly referred to as the LCR holocomplex [30,31].
`Evidence supporting the holocomplex model came from
`the genetic analysis of mutant LCRs in transgenic assays
`[31–34]. Deletion of individual LCR HS elements in single-
`copy YAC transgenes led to strong reductions in globin
`gene expression and also impaired the formation of
`DNase I HS sites associated with the LCR and the globin
`gene promoters. These data suggest that LCR HS site
`deletions render the LCR unable to protect from position-
`of-integration effects in transgenic studies [32]. In contrast
`with these findings, the consequence of deleting HS sites
`from the endogenous mouse locus on globin gene expression
`is much milder and does not appear to affect the formation
`of remaining HS sites [35–37]. The different results from
`studies of globin locus transgenes vs. endogenous loci could
`be explained in several ways [38]. First, the differences could
`solely be based on the observation that an incomplete LCR
`is not able to confer position-independent chromatin
`opening and gene expression in the globin locus at ectopic
`sites. Secondly, differences in the size of the deleted
`fragments could result in different phenotypes. The most
`severe effects on globin gene expression were observed in
`those transgenes in which only the 200–400-bp (cid:212)core(cid:213)
`enhancer elements were deleted. All the experiments in the
`endogenous murine globin locus removed the cores together
`with the flanking sequences. Finally, it is possible that the
`endogenous murine globin locus contains sequences in
`addition to the LCR that are able to provide an open
`chromatin configuration.
`Recently, Hardison and colleagues analyzed the function
`of LCR HS sites in the presence or absence of the HS core
`flanking sequences in murine erythroleukemia (MEL) cells
`using recombination mediated cassette exchange [39]. At
`several fixed positions,
`the inclusion of
`the flanking
`sequences leads to a synergistic enhancement of expression
`by the combination of HS units, whereas combining the
`core HS elements only additively enhanced reporter gene
`expression. Similarly, May et al.
`[40] showed that the
`combination of HS2, 3, and 4 led to therapeutic levels of
`
`b-globin gene expression in b-thalassemic mice only in the
`presence of sequences flanking the LCR HS cores. Taken
`together, the data suggest that the HS units interact with
`each other to generate an LCR holocomplex, formation of
`which is required for high-level b-globin gene expression.
`The flanking sequences could be important in positioning
`the HS core elements in ways that facilitate their interactions
`[39].
`
`L C R I N T E R A C T I N G P R O T E I N S
`
`Knowledge about the proteins that interact with the LCR
`in vivo is very limited. Here we will focus on more recent
`results describing the activities of specific proteins or protein
`complexes implicated in LCR function. For a more
`comprehensive summary of proteins interacting with regu-
`latory sequences throughout the globin locus, we would like
`to refer the reader to previous reviews [1,24].
`The DNA sequence motifs that are most conserved
`among different species are MARE (maf recognition
`element) and GATA sequences in HS2, 3 and 4, KLF-
`binding sites in HS2 and HS3, and an E-box motif in HS2
`[24]. MARE sequences are bound in vitro by a large number
`of different proteins that all heterodimerize with small maf
`proteins [41]. Individual members of
`this family are
`characterized by the presence of leucine zipper motifs, the
`founding member being NF-E2 (p45) [42]. Other members
`of this family also expressed in erythroid cells are Bach1,
`NRF1 and NRF2 (NF-E2 related factor 1 and 2) [43–45].
`A variety of data suggest a pivotal role for p45 in LCR
`function [42,46]. However, gene ablation studies have
`shown that erythropoiesis is not affected in mice lacking
`NF-E2 (p45), NRF1 or NRF2, suggesting functional
`redundancy among the NF-E2 family members in erythroid
`cells [47–49].
`It should be noted that, although the NF-E2-like proteins
`are all thought to interact with the same DNA-binding site,
`they are structurally different. Bach1 for example contains a
`BTB/Poz domain and forms oligomers while bound to
`DNA in vitro [50]. This observation prompted investigators
`to analyze whether Bach1/small maf heterodimers could
`simultaneously bind to HS2, 3, and 4 and mediate the
`interaction between the core elements [51]. Using atomic
`force microscopy,
`it was shown that Bach1-containing
`heterodimers could indeed cross-link HS sites in vitro,
`indicating that proteins exist that bind to the LCR and are
`able to mediate the interaction of HS sites. Importantly, this
`activity of Bach1 depends on the presence of the BTB/Poz
`domain.
`The CACCC sites in HS2 and HS3 are probably bound
`in vivo by EKLF. First, transgenic mice containing the
`human b-globin locus and lacking EKLF exhibit a reduc-
`tion in the formation of HS3 [13]. In addition, using the
`Pin-Point assay, Lee et al. [52] demonstrated that EKLF
`binds to both HS2 and HS3 in vivo. Interestingly, the
`binding of EKLF to HS3 is reduced in the absence of HS2,
`suggesting some form of communication between these two
`elements [52].
`The GATA sites are bound by either GATA-1 or
`GATA-2, the only two members of the GATA family of
`transcription factors known to be expressed in erythroid
`cells [53]. GATA-1 is one of the earliest markers in red cell
`differentiation and is detectable in progenitor cells that do
`
`

`
`1592 P. P. Levings and J. Bungert (Eur. J. Biochem. 269)
`
`(cid:211) FEBS 2002
`
`not yet express the globin genes [54]. Interestingly, LCR HS
`sites are already detectable in these undifferentiated precur-
`sor cells [55]. These results suggest that GATA-1 may be
`involved in the regulation of chromatin structure at an early
`stage of erythroid differentiation.
`The E-box in HS2 interacts with helix–loop–helix (HLH)
`proteins in vitro, and both USF and Tal1 were shown to
`interact with this element [56,57]. USF is a ubiquitously
`expressed member of the HLH family of proteins and binds
`to DNA as a heterodimer usually composed of USF1 and
`USF2. USF has been implicated in the regulation of many
`genes and normally acts as a transcriptional activator.
`However, it has also been reported to function through
`initiator elements, in which case it mediates the recruitment
`of Pol II transcription complexes [58,59]. Tal1 is hemato-
`poietic specific and appears to function at an early step
`during the specification of hematopoietic progenitor cells
`[60].
`Protein–protein interactions probably play important
`roles in LCR function. We have already discussed the
`multimerization of Bach/maf heterodimers. Other protein–
`protein interactions known to occur among LCR-binding
`proteins involve those between the GATA factors and
`between GATA factors and EKLF, LMO2/Tal1, and Sp1
`[61–63]. In addition, GATA-1, EKLF and NF-E2 (p45)
`were shown to interact with coactivators and acetyltrans-
`ferase activities [64,65]. EKLF has also been demonstrated
`to interact with members of the Swi/SNF family of
`chromatin-remodeling complexes [14]. These results show
`that most proteins binding to one LCR core element have
`the potential to interact with proteins binding to another
`LCR core HS site, which could initiate and stabilize an LCR
`holocomplex. In addition, the results also demonstrate that
`LCR-interacting proteins recruit macromolecular com-
`plexes involved in chromatin remodeling and histone
`acetylation.
`
`R E P L I C A T I O N A N D C H R O M A T I N
`S T R U C T U R E
`The human b-globin locus replicates early in erythroid cells
`and late in nonerythroid cells. Earlier studies suggested that
`the LCR regulates the timing and usage of an origin of
`replication located between the d-globin and b-globin gene
`[66]. This interpretation was based on the observation that a
`large deletion in the human b-globin locus, starting
`immediately upstream of HS1 and spanning about 30 kb,
`inactivates the entire globin locus [66]. The globin genes
`linked to this deletion are not transcribed, the locus becomes
`late replicating, and remains in a DNase I-resistant and
`inaccessible configuration. However, recent analysis of the
`consequence of a targeted deletion of the LCR demonstrates
`that the LCR regulates neither the timing of replication in
`the globin locus nor the usage of the replication origin [67].
`Thus, a putative element regulating replication timing in the
`human b-globin locus must be located 5¢ to the LCR.
`An important question that has to be addressed is
`whether activation of the globin locus and LCR function
`requires replication. During differentiation of erythroid
`cells, the locus undergoes various transitions, the first of
`which is the formation of DNase I HS sites in the LCR [55].
`Does the formation of HS sites at this early stage in
`differentiation require replication? In other words, do the
`
`proteins responsible for HS site formation require a window
`of opportunity after replication to bind and then prevent the
`generation of repressive chromatin structure or do these
`proteins recruit chromatin-remodeling activities that change
`the chromatin structure in a replication-independent man-
`ner? Experiments that indirectly addressed this issue were
`those in which investigators generated heterokaryons with
`MEL cells, which represent definitive erythroid cells that
`express the adult b-globin gene, and human K562 cells,
`which represent primitive erythroid cells that express the
`e-globin gene [68]. These studies showed that trans-acting
`factors in the MEL cells are able to activate transcription of
`the human b-globin gene. Interestingly,
`the onset of
`b-globin gene expression in these experiments occurred
`about 12 h after fusion. Because the globin locus replicates
`early in erythroid cells, these results could be interpreted to
`mean that replication is required for trans-activation of the
`human b-globin genes in the heterokaryons. On the other
`hand, this experiment could also lead to the interpretation
`that the human locus can be activated by transcription
`factors and accessory proteins already present in the adult
`(MEL) erythroid cells. This mode of regulation would be
`similar to the induction of genes by hormone receptors [69].
`However, differences in the two systems may exist, as the
`globin locus is a developmentally regulated locus, the
`expression of which changes as the cell differentiates. Genes
`regulated by hormone and orphan receptors are transcribed
`in mature cells and their expression is regulated by external
`stimuli, i.e. hormones. Obviously more studies are needed
`that examine the relationship between replication and
`chromatin structure in the globin locus. For example, it
`would be interesting to examine the binding of chromatin
`components and transcription factors during the cell cycle in
`erythroid cells.
`
`I N T E R G E N I C T R A N S C R I P T S
`I N T H E G L O B I N L O C U S
`
`In 1992, Tuan et al. [70] reported that long transcripts
`initiate within LCR HS2 and proceed in a unidirectional
`manner toward the globin genes. Further studies by the
`same group led to the startling observation that transcrip-
`tion always proceeds in the direction of a linked gene,
`independent from the orientation of HS2 [71]. This result
`suggests some form of communication between the promo-
`ter and LCR HS2 in these experiments. Subsequent studies
`in the laboratories of Proudfoot [72] and Fraser [7] identified
`noncoding transcripts over the entire LCR and in between
`the globin gene coding regions. Interestingly, the pattern of
`intergenic transcription during development appears to
`correlate with the pattern of general DNase I sensitivity [7].
`Mutations that delete the start site of the adult-specific
`intergenic transcripts lead to a decrease in general DNase I
`sensitivity and b-globin gene transcription, suggesting that
`intergenic transcription modulates the chromatin structure
`of globin locus subdomains. Intergenic transcripts appear to
`be generated in a cell-cycle-dependent manner, detectable
`during early S-phase but predominantly present in G1 [7].
`These results provide evidence for the hypothesis that
`intergenic transcription is transient. Recently Plant et al.
`[73] analyzed intergenic transcripts across the globin locus
`by nuclear run-on analysis and did not find any evidence for
`the stage-specific generation of
`these transcripts. The
`
`

`
`(cid:211) FEBS 2002
`
`Multistep model for locus control region function (Eur. J. Biochem. 269) 1593
`
`discrepancy between this study and that of Gribnau et al. [7]
`is not understood at the moment, but it is possible that at
`certain stages of the cell cycle, the entire locus is transcribed
`for a short period of time. A subsequent step could then shut
`off transcription in silenced domains, but reduced tran-
`scription could still be detectable by the more sensitive assay
`employed by Plant et al. [73].
`
`I N S U L A T O R S
`The chicken b-globin locus is flanked by insulator elements
`which mark clear boundaries between active and inactive
`chromatin [74,75]. No such sequences have been conclu-
`sively identified in the human or murine globin locus, and it
`appears that the DNase I-sensitive domain in these loci
`extend far 5¢ of the LCR and far 3¢ of the b-globin gene.
`Recent experiments distinguish between insulator sequences
`that block the action of an enhancer or silencer and that of
`boundary elements that separate open and closed chromatin
`domains [74]. The 5¢ most HS site of the chicken LCR, HS4,
`appears to harbor both activities [75]. In this sense it is quite
`possible that the human b-globin locus contains insulator
`elements that restrict the action of the LCR to within
`specific domains. Some evidence suggests that HS5 may
`harbor insulator activity. First, HS5 harbors a binding site
`for the protein CTCF, which is largely responsible for
`insulator function of chicken HS4 [76]. Secondly, inversion
`of the entire LCR with respect to the genes reduces globin
`gene expression to less than 30% of wild-type levels [21].
`Thirdly, an e-globin gene placed upstream of the LCR is not
`transcribed [21]. Finally, HS5 was shown to exhibit
`insulator activity in cell culture experiments [77].
`
`N U C L E A R L O C A L I Z A T I O N
`
`Recent data suggest that enhancer and other regulatory
`elements affect the position of genes within the nucleus
`[78,79]. For example, it was shown that in the absence of
`the b-globin gene is located close to
`an enhancer,
`centromeric heterochromatin, an environment within the
`nucleus that is incompatible with transcription [80]. In the
`presence of LCR element HS2, the b-globin gene localizes
`away from centromeric heterochromatin, suggesting that
`activities associated with HS2 are able to relocate the
`transgene to a transcriptionally permissive nuclear region
`[80]. This phenomenon has been most intensively analyzed
`in yeast, in which specific protein complexes appear to
`direct the location of genes into active or inactive regions
`of the nucleus [81]. However, Milot et al. [32] showed that
`a wild-type globin locus that integrated close to centro-
`meric heterochromatin was still active, suggesting that, in
`the presence of the LCR, the globin locus is active even
`when situated close to a defined heterochromatic envi-
`ronment.
`Recent advances in fluorescent labeling of chromatin as
`well as three-dimensional fluorescent microscopy indicate
`that chromosomes occupy distinct regions, or domains,
`within the cell nucleus [82]. These chromosome domains
`may be composed of up to 1 Mb of chromatin supported by
`the nuclear architecture and appear to contain loops of
`about 50–200 kb of DNA possessing one or several gene
`loci that may or may not be co-regulated. The spaces
`between these territories are believed to be occupied by a
`
`(cid:212)matrix(cid:213)-like structure, consisting of filamentous proteins,
`which is defined as the interchromosomal domain (ICD).
`Active gene loci are located at the surface of chromosomal
`domains in direct contact with the ICD, whereas inactive
`loci are located away from the ICD within chromosomal
`domains. It
`is proposed that macromolecular protein
`complexes involved in chromatin remodeling, transcription,
`and splicing are enriched in the ICD, whereas single proteins
`or smaller protein complexes can diffuse into regions of the
`chromatin domains that are not in contact with the ICD.
`The former ideas are based on indirect observations using
`microscopy and fluorescent labeling. We can therefore only
`describe the existence of chromosome territories and the
`ICD as speculative at best. However, it is safe to say that
`gene loci are located in specific regions of the nucleus and
`that the relative position of these loci changes on activation.
`If applied to the regulation of the globin genes, the ICD
`model could explain why deletion of the LCR in the
`endogenous human or murine globin loci silences globin
`gene expression without altering the establishment of
`DNase I and hyperacetylated chromatin. It is possible that
`transcription factors could gain access to the globin locus
`and change higher-order chromatin structure, but that the
`LCR is required to organize the globin locus in a way that it
`is located in close proximity to the ICD. The situation is
`similar in concept to mechanisms described for the regula-
`tion of gene loci during differentiation of B-lymphocytes.
`Fisher and colleagues [79] have shown that specific gene loci
`relocate to inactive regions in the nucleus of cycling B-cells.
`The relocation and inactivation is regulated by the DNA-
`binding protein Ikaros, which mediates the association of
`gene loci with centromeric heterochromatin.
`
`A M U L T I S T E P M O D E L F O R H U M A N
`b-G L O B I N G E N E R E G U L A T I O N
`
`Step 1: generation of a highly accessible
`LCR holocomplex
`
`We propose that the first step towards activation of the
`globin genes during differentiation is the partial unfolding of
`the chromatin structure containing the globin locus into a
`DNase I-sensitive domain (Fig. 2A). This step may or may
`not require replication. The initial unfolding of
`the
`chromatin structure is mediated by the diffusion of eryth-
`roid-specific proteins into chromosomal domains that are
`not permissive for transcription. These proteins bind to
`sequences throughout the globin locus leading to the partial
`unfolding and perhaps hyper-acetylation of the chromatin.
`If replication is required for globin locus activation, we
`propose that erythroid-specific proteins bind to the globin
`locus after DNA synthesis, prevent the formation of
`repressive chromatin, and mark the locus by modification
`of histone tails.
`GATA factors may be involved in the initial step of
`globin locus activation, as their binding sequences are
`located throughout the globin locus. In addition, GATA-1
`is one of the earliest markers of red cell differentiation [54]
`and is known to associate with proteins containing histone
`acetyltransferase activities. The partial unfolding into a
`DNase I-sensitive structure does not require activities
`associated with the LCR. This is shown by the fact that
`even in the absence of an intact LCR, the rest of the globin
`
`

`
`1594 P. P. Levings and J. Bungert (Eur. J. Biochem. 269)
`
`(cid:211) FEBS 2002
`
`Fig. 2. Multistep model for human b-globin gene regulation. The model depicts four steps proposed to be involved in the regulation of chromatin
`structure and gene expression in the human b-globin locus. The model focuses on the regulation of the human globin locus in the context of
`transgenic mice, but it is assumed that the same principal mechanisms govern the co

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket